BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 37369093)

  • 21. Genetic risk assessments in individuals at high risk for inherited breast cancer in the breast oncology care setting.
    Pal T; Vadaparampil ST
    Cancer Control; 2012 Oct; 19(4):255-66. PubMed ID: 23037493
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improving the referral process for familial breast cancer genetic counselling: findings of three randomised controlled trials of two interventions.
    Wilson BJ; Torrance N; Mollison J; Wordsworth S; Gray JR; Haites NE; Grant A; Campbell MK; Miedyzbrodzka Z; Clarke A; Watson MS; Douglas A
    Health Technol Assess; 2005 Feb; 9(3):iii-iv, 1-126. PubMed ID: 15694064
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Breast and ovarian cancer referrals to the ACT Genetic Service: are we meeting guidelines?
    Aitken L; Warwick L; Davis A
    Intern Med J; 2017 Mar; 47(3):311-317. PubMed ID: 28019080
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An analysis of the impact of annual cancer genetic testing guideline updates on a past patient population.
    Johnson J; Hogan E; Merrill M; Noss R
    J Genet Couns; 2023 Oct; ():. PubMed ID: 37907432
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Frequency of germline pathogenic variants in breast cancer predisposition genes among young Turkish breast cancer patients.
    Isiklar AD; Aliyeva L; Yesilyurt A; Soyder A; Basaran G
    Breast Cancer Res Treat; 2023 Nov; 202(2):297-304. PubMed ID: 37615792
    [TBL] [Abstract][Full Text] [Related]  

  • 26. BRCAsearch: written pre-test information and BRCA1/2 germline mutation testing in unselected patients with newly diagnosed breast cancer.
    Nilsson MP; Törngren T; Henriksson K; Kristoffersson U; Kvist A; Silfverberg B; Borg Å; Loman N
    Breast Cancer Res Treat; 2018 Feb; 168(1):117-126. PubMed ID: 29164420
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Value of a genetics clinic evaluation in identifying women at risk for hereditary breast-ovarian cancer syndrome.
    Hinshaw JC; Zhao LP; Brimm JE; Payne TH; Hisama FM
    J Genet Couns; 2021 Dec; 30(6):1591-1597. PubMed ID: 33881185
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Psychosocial predictors of BRCA counseling and testing decisions among urban African-American women.
    Thompson HS; Valdimarsdottir HB; Duteau-Buck C; Guevarra J; Bovbjerg DH; Richmond-Avellaneda C; Amarel D; Godfrey D; Brown K; Offit K
    Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1579-85. PubMed ID: 12496047
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Implementation of a quality improvement project for universal genetic testing in women with ovarian cancer.
    Uyar D; Neary J; Monroe A; Nugent M; Simpson P; Geurts JL
    Gynecol Oncol; 2018 Jun; 149(3):565-569. PubMed ID: 29653687
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of an embedded genetic counselor on breast cancer treatment.
    Pederson HJ; Hussain N; Noss R; Yanda C; O'Rourke C; Eng C; Grobmyer SR
    Breast Cancer Res Treat; 2018 May; 169(1):43-46. PubMed ID: 29349711
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Provider discussion of genetic counseling among high-risk Spanish-preferring Latina breast cancer survivors.
    Conley CC; Rivera Rivera JN; Castro-Figueroa EM; Moreno L; Dutil J; García JD; Ricker C; Quinn GP; Soliman H; Vadaparampil ST
    Transl Behav Med; 2022 Oct; 12(9):900-908. PubMed ID: 36205471
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Why Is Cancer Genetic Counseling Underutilized by Women Identified as at Risk for Hereditary Breast Cancer? Patient Perceptions of Barriers Following a Referral Letter.
    Kne A; Zierhut H; Baldinger S; Swenson KK; Mink P; Veach PM; Tsai ML
    J Genet Couns; 2017 Aug; 26(4):697-715. PubMed ID: 27826805
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Electronic health records contain dispersed risk factor information that could be used to prevent breast and ovarian cancer.
    Payne TH; Zhao LP; Le C; Wilcox P; Yi T; Hinshaw J; Hussey D; Kostrinsky-Thomas A; Hale M; Brimm J; Hisama FM
    J Am Med Inform Assoc; 2020 Jul; 27(9):1443-1449. PubMed ID: 32940694
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mainstreaming cancer genetics: A model integrating germline BRCA testing into routine ovarian cancer clinics.
    Kentwell M; Dow E; Antill Y; Wrede CD; McNally O; Higgs E; Hamilton A; Ananda S; Lindeman GJ; Scott CL
    Gynecol Oncol; 2017 Apr; 145(1):130-136. PubMed ID: 28162234
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Perioperative genetic testing and time to surgery in patients with breast cancer.
    Wu V; Chichura AM; Dickard J; Turner C; Al-Hilli Z
    Surgery; 2024 Mar; 175(3):712-717. PubMed ID: 37848355
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic counseling and testing for females at elevated risk for breast cancer: Protocol for the randomized controlled trial of the Know Your Risk intervention.
    Sweet K; Reiter PL; Schnell PM; Senter L; Shane-Carson KP; Aeilts A; Cooper J; Spears C; Brown J; Toland AE; Agnese DM; Katz ML
    Contemp Clin Trials; 2023 Oct; 133():107323. PubMed ID: 37661005
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Underdiagnosis of Hereditary Breast Cancer: Are Genetic Testing Guidelines a Tool or an Obstacle?
    Beitsch PD; Whitworth PW; Hughes K; Patel R; Rosen B; Compagnoni G; Baron P; Simmons R; Smith LA; Grady I; Kinney M; Coomer C; Barbosa K; Holmes DR; Brown E; Gold L; Clark P; Riley L; Lyons S; Ruiz A; Kahn S; MacDonald H; Curcio L; Hardwick MK; Yang S; Esplin ED; Nussbaum RL
    J Clin Oncol; 2019 Feb; 37(6):453-460. PubMed ID: 30526229
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protocol to evaluate sequential electronic health record-based strategies to increase genetic testing for breast and ovarian cancer risk across diverse patient populations in gynecology practices.
    Symecko H; Schnoll R; Beidas RS; Bekelman JE; Blumenthal D; Bauer AM; Gabriel P; Boisseau L; Doucette A; Powers J; Cappadocia J; McKenna DB; Richardville R; Cuff L; Offer R; Clement EG; Buttenheim AM; Asch DA; Rendle KA; Shelton RC; Fayanju OM; Wileyto EP; Plag M; Ware S; Shulman LN; Nathanson KL; Domchek SM
    Implement Sci; 2023 Nov; 18(1):57. PubMed ID: 37932730
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Eligibility criteria in private and public coverage policies for BRCA genetic testing and genetic counseling.
    Wang G; Beattie MS; Ponce NA; Phillips KA
    Genet Med; 2011 Dec; 13(12):1045-50. PubMed ID: 21844812
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recruiting African American women to participate in hereditary breast cancer research.
    Halbert CH; Brewster K; Collier A; Smith C; Kessler L; Weathers B; Stopfer JE; Domchek S; Wileyto EP
    J Clin Oncol; 2005 Nov; 23(31):7967-73. PubMed ID: 16258097
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.